# Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder

> **NCT01920412** · EARLY_PHASE1 · COMPLETED · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Atrial Fibrillation
- Stroke

## Interventions

- **DEVICE:** LAmbre Left Atrial Appendage(LAA) Occluder

## Key facts

- **NCT ID:** NCT01920412
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2014-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920412, "Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01920412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*